Agranolocytosis screening procedure

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5223399
SERIAL NO

07671587

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Certain patients undergoing clozapine drug therapy may be vulnerable to agranulocytosis. It has been found that agranulocytosis vulnerability is correlated with the presence of HLA antigens B38, DR4 and DQw3. Accordingly, a method is provided for detecting such patients, and an HLA kit is provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DANA-FARBER CANCER INSTITUTE44 BINNEY STREET BOSTON MA 02115 BOSTON MA 02115

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lieberman, Jeffrey A New York, NY 2 8
Yunis, Edmond J Concord, MA 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation